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ABSTRACT This article provides an overview of outstanding sessions that were (co)organised by the
Allied Respiratory Professionals’ Assembly during the European Respiratory Society International Congress
2019 in Madrid, Spain. Session content was mainly targeted at allied respiratory professionals such as
respiratory physiologists, respiratory physiotherapists and respiratory nurses, and is summarised in this
document. Short take-home messages related to pulmonary function testing highlight the importance of
quality control. Furthermore, novel findings regarding the assessment of functional status call attention to
bodily factors that can affect functional status. Regarding pulmonary rehabilitation, data were presented
about the use of equipment and type of exercise training in COPD and lung cancer. Recent developments
in physical activity-related research give insight in enablers of physical activity after hospital admission.
The importance of integrated respiratory care was also highlighted, with the occupational therapist, nurse,
and nutritional and psychological counsellor playing a pivotal role, which relates directly to research in the
field of respiratory nursing that formulates the need for more nursing led-interventions in the future. To
conclude, this review provides readers with valuable insight into some of the emerging and future areas
affecting clinical practice of allied healthcare professionals.
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CONGRESS HIGHLIGHTS
ALLIED RESPIRATORY PROFESSIONALS
Introduction
The 2019 European Respiratory Society (ERS) International Congress offered allied respiratory professionals
a wide range of appealing sessions, i.e. one postgraduate course, three skills workshop, one professional
development workshop, two symposia, and 266 presentations spread over three oral presentation sessions,
four poster discussions and nine thematic poster sessions. Early career members of the Allied Respiratory
Professionals’ Assembly, including respiratory physiologists (A. O’Rourke and M. Rutter), respiratory
physiotherapists (B. Herrero-Cortina and A. Oliveira) and respiratory nurses ( J.C.Quijano-Campos and
M. Clari), were asked to report on the following selected sessions by group chairs of the assembly, which
focus on recent practical guidelines regarding testing and recent research advances: a skills workshop on
diffusing capacity testing, a thematic poster session on nursing care across the spectrum of respiratory
illness, two oral presentation sessions on functional status assessment and on rehabilitation and physical
activity in respiratory patients, and two well-attended symposia on quality control of lung function testing
and on the added value of allied healthcare professionals (AHPs) in integrated respiratory care. The reports
that follow attempt to summarise some of the latest scientific and clinical insights gained from each session,
targeting delegates who were present in Madrid as well as those unable to attend in person.
Symposium on “New insights into quality control of lung function testing”
The symposium started with a heartfelt tribute to Maureen Swanney, who dedicated her working life to
furthering the field of respiratory physiology and putting others first. She was instrumental in the scope
and accreditation of respiratory physiology departments, and had a passion for the quality and
standardisation of lung function tests. Maureen was one of the co-authors of the American Thoracic
Society (ATS)/ERS technical standard on spirometry featured in this symposium [1]. Prior to this, she had
worked on improving lung function interpretation: encouraging the use of universal lung function
reference equations [2–4], and using lower limits of normal instead of percent predicted and fixed
thresholds [5, 6]. She had an appreciation for local quality-assured spirometry and wanted to share this
practice with other professionals, setting minimum standards for training and competency requirements [7].
The focus of her PhD work was the validation of the forced expiratory volume in 6 s to make lung
function more accessible in primary care whilst maintaining quality and safety for patients [8]. She was
recognised nationally and internationally, and is an exemplary role model for all women in science,
inspiring respiratory physiologists and scientists alike.
Maureen was due to present on quality assurance, which was such a key aspect of her work. The role of quality
assurance programmes for respiratory physiology testing is regarded as best practice and was the focus of the
first talk entitled “What’s new in spirometry biological quality control” by B. Thompson (Australia). A review
of primary care practice in Australia [9] revealed a lack of understanding of the simplest quality assurance
practices and that equipment manufacturers were not promoting calibration syringes for calibration verification
checks. Biological quality control (BioQC) testing is also considered best practice, ensuring the quality of results
and allowing identification of issues with the equipment and software [10, 11]. Data presented showed that the
evidence demonstrating the benefits of using BioQC data is minimal. Standards recommend that BioQC
subjects be healthy [10]; however, the recommendations do not account for inherent variability such as
ageing. Other issues identified were that, in departments with multiple pieces of equipment, the process is
time consuming and requires enough staff numbers to perform quality assurance daily or weekly. The
recommendations are to replace BioQC with quality control processes using mechanical devices such as
calibrated syringes, isothermal lungs, waveform generators and simulators for lung function testing.
Having ensured the equipment is operating accurately, confirming the tests are performed to a high
standard is also vital. An update on the ATS/ERS technical standard on spirometry was given by
B. Graham (Canada) [1], reflecting changes in technology and best practice for spirometry performance.
Six main areas of improvement were identified: patients, equipment, operator, procedure, analysis and
quality assessment. These are presented in table 1.
Spirometry is a large part of respiratory diagnostics; however, other tests require the same high
standards. A. Kendrick (UK) followed with his talk on “How to remain in line with the new DLCO/DLNO
guidelines”. The diffusing capacity of the lung for carbon monoxide (DLCO) and diffusing capacity of the
lung for nitric oxide (DLNO) guidelines [11, 13] have been updated to include both classic and rapid gas
analysers (RGAs), the latter improving test quality in both methods. Test gas mixtures have been
standardised to include the tracer gas nitric oxide and fractional inspired oxygen set to 21%. The
acceptability and repeatability criteria have been revised, introducing a quality control grading system.
There are quality assurance process recommendations to ensure accurate measurement. A key aspect of
quality assurance is a DLCO simulator, which identifies instrument failures not recognised by routine
quality control and calibration procedures [14]. Regular simulator use leads to improved confidence in
result accuracy for patient management benefit.
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Cardiopulmonary exercise testing (CPET), more so than its less intricate counterparts, requires a stringent
quality control process due to the complexity of measurements incorporating ventilation, cardiac and
metabolic components. M. Johnson (UK) recognised three areas that impact the quality control of CPET
(hardware, subject testing and data processing) in her talk “Cardiopulmonary exercise testing: can you trust
the data?”. Hardware relies on verification checks of flow sensor and gas analysers. Delay time between
sample collection at the mouth and gas analysis is incredibly important; if delay time is incorrectly set,
variation between measured and actual results increases with test duration [15]. Systems can be verified
using BioQC to indicate equipment precision rather than accuracy, and simulators, although not widely
available, provide data on accuracy but not precision. It is important to check equipment such as
ergometers or treadmills, calibration syringes, and gas cylinder concentration regularly, as these can
introduce errors not routinely identified through calibration. During subject testing, there are multiple
sources of error; therefore, it is important to check the data are as expected. Sources of error are the
ergometer or treadmill, mask leaks, sample line collection, ECG variability (abnormality or artefact), and
blood gas sampling time. The data processing relies on using a standardised method for data averaging and
data being presented in the conditions it was measured (e.g. body temperature and pressure, saturated
(BTPS)). There are a wide range of reference values available; therefore, selection should represent the
population being measured utilising the same measurement method (e.g. ergometer or treadmill).
With all the quality control processes in place, it is important to understand if they are being maintained
and if not, what led to the failures. A quality data management (QDM) process introduces precision and
accuracy of measurements undertaken, and reduces potential errors, as emphasised by J. Blonshine (USA)
in his talk on “Recent advances in data management”. QDM improves efficiency and supports the
standards required for accreditation. Guidelines recommend regular checks but multiple factors must be
considered when designing a QDM; frequency of checks should be relative to the volume of tests
performed and the number of devices/staff available. The presented data demonstrated that failures in
calibration were often related to performance of checks as opposed to actual equipment faults. The
recommended QDM process should start with the simplest checks first and then progress to the most
complex, with errors being rectified at each stage of identification. The multilayered approach utilises
multiple methods of quality control, and understanding of what is being measured and why they fail. This
means that most errors will be preventable.
TABLE 1 Updated areas of the American Thoracic Society/European Respiratory Society technical standard on spirometry
Patients Equipment Operator Procedure Analysis Quality assessment
Patient safety
Relative
contraindication
Activities to avoid
Medication withhold
times
Within-test feedback
for achieving full
exhalation
Equipment
complies with
ISO standard
Error tolerances
of ±2.5%
Measurement of
inspiration and
expiration
Revised calibration
verification
checks
Introduced
warning
messages
Required to
complete
competency
assessments
Operators should
have adequate
training to
perform
spirometry
Tidal breathing prior to
rapid inspiration to
maximal lung
volume
Full expiration with
maximal effort
Maximal inspiration
back to maximal
lung volume
End of forced
expiration criteria
requires a plateau
and maximum
exhalation time of
15 s
Minimum of 6 s
expiratory time
removed
Acceptability and
reproducibility
criteria
Methodology for
bronchodilator
response testing
Updated definitions
and criteria for
analysis of
manoeuvres
Standardised cues,
feedback and
warnings to
operator
Use of the ATS
standardised report
[12]
Data storage and
electronic patient
records to comply
with data protection
ISO: International Organization for Standardization; ATS: American Thoracic Society.
Take-home messages
In summary, to have a quality-assured diagnostic service, it is necessary:
• To understand the quality control mechanisms and their limitations in the context of patient testing.
• To have up-to-date processes incorporating best practice from current guidelines.
• Introduce a QDM process to monitor quality control and identify/prevent errors.
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Skills workshop on diffusing capacity testing
Specialists in respiratory physiology delivered two skills workshops focused on the 2017 ERS/ATS
standards for diffusing capacity testing of the lung [11]. The aim of these workshops was to better inform
current practice through small group education targeting the following four key areas that are discussed
below. Table 2 is provided as a summary of the highlights from each of the four workstations.
Calibration, quality control and system settings
F. Burgos (Spain) and F. De Jongh (The Netherlands)
This workstation aimed to demonstrate best practice for RGA, quality control and appropriate system
settings to achieve accurate testing according to the 2017 standards. There were four main areas discussed
during this workstation presentation: calibration, technical aspects of a RGA, the problem of potential
leaks and the influence of ambient conditions on test quality. A clear understanding of these factors and
how they impact the quality of results is fundamentally important to safeguard against poor practice and
erroneous results. It was advocated to ensure the accuracy of the thermometer and barometer used for
checking ambient conditions, in order to optimise quality. Furthermore, we should check the system
settings such as dead space, pressure range, volume and BTPS factor, and should ensure that calibration
for volume and pressure is accurate by checking whether the calibration syringe is within range, with proof
of date of calibration and volume accuracy at different flow rates. Record keeping of trouble shooting, any
system problems, and tracking of service and maintenance should be maintained. When upgrading
software and equipment one needs to confirm that the DLCO is correct using quality control measures.
Regular gas checks using a calibration syringe or DLCO simulator was also recommended.
Technical aspects of diffusing capacity testing
A. Kendrick (UK) and B. Cooper (UK)
KROGH [16] developed the first method to measure the single-breath uptake of carbon monoxide in 1915.
Her research was designed to show that passive diffusion could explain oxygen transfer from the alveolar
gas to the pulmonary capillary blood. Additionally, this approach sets the grounds for the current
TABLE 2 Synopsis of the diffusing capacity of the lung for carbon monoxide (DLCO) skills workshop
Calibration, QC and settings Technical aspects Standardisation of test performance Reporting and
interpretation
Check ambient conditions (use a
reliable barometer and
thermometer)
Ensure the correct system
settings for dead space,
pressure range, volume, and
BTPS correction
Accurate calibration for volume
and pressure
Check volume accuracy ±75 mL
0–90% response time ⩽150 ms
Linearity: ⩽0.5% of full scale
Accuracy: ±1% of full scale
Adjust for lag and response time
QC using regular biological
controls
Quality assurance using syringe
or DLCO gas simulator
Interference from 5%
CO2 or 5% water
vapour ⩽10 ppm error
in CO
Drift for CO ⩽10 ppm
over 30 s
Drift for tracer gas
⩽0.5% of full scale
over 30 s
BHT 10±2 s
Maximum time for unforced exhalation to RV is
⩽12 s
Vinsp target of ⩾90% of largest VC in same lung
function testing session
Vinsp ⩾85% of VC is acceptable if VA is within 200 mL
or 5% of highest VA from acceptable DLCO trial
Vinsp must be <4 s, longer Vinsp must be noted on
report
Exhalation post-BHT past sample collection on
classic systems <4 s
Exhalation to RV post BHT on RGA systems can be
up to 12 s
Between test wait time: 4 min, 10 min for patient
with severe airflow obstruction (on RGA, check
tracer gas concentration at end-exhalation ⩽2%
of the inspired concentration)
Must remain seated during wait time
Recommended to check end-exhalation CO levels
prior to inhalation of test gas; this can be used to
adjust to the test for CO back-pressure and
calculate COHb; allows compensation for water
vapour and CO2 effects
Repeatability requirement: there must be at least
two acceptable manoeuvres that are within
2 mL·min−1·mmHg−1 (0.67 mmol·min−1·kPa−1) of
each other
Record when last
cigarette was smoked
Always use DLCO
corrected for Hb and
COHb where
applicable
Clearly state if no recent
Hb is available
Report the grading of
the DLCO manoeuvres
Record altitude
QC: quality control; BTPS: body temperature and pressure, saturated; BHT: breath-holding time; RV: residual volume; Vinsp: inspiratory
volume; VC: vital capacity; VA: alveolar volume; RGA: rapid gas analyser; COHb: carboxyhaemoglobin; Hb: haemoglobin.
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methodology. The linearity of gas concentration signals is of most importance in measuring DLCO since
the ratios of the gas concentrations are considered in the classical calculations. Water vapour and carbon
dioxide in exhaled gas are contributing factors in interface noise of up to 5%; i.e. water vapour pressure
6.28 kPa (47 mmHg) should contribute <10 ppm error in the measured carbon monoxide signal, while gas
analysers should only have minimal drift in zero and gain, so that the output is stable over the test
interval. Gas analyser drift must be ⩽10 ppm over 30 s for carbon monoxide and ⩽0.5% of full scale over
30 s for the tracer gas.
Standardisation of test performance
A. McGowan (Ireland) and K. Sylvester (UK)
The DLCO technique was first standardised by Ogilvie and co-workers in 1957 [17]. A tracer gas was used
to determine both the alveolar volume and the alveolar concentration of carbon monoxide at the
beginning of breath holding. This method used the collection of discrete exhaled gas samples from which
gas concentrations were measured using gas analysers that took several minutes to perform the
measurements. The instrumentation for DLCO measurement has advanced considerably since then,
primarily through the use of RGA systems. The 2017 standard provides more detail on how the test
should be performed when using real time gas analysers.
The new standards of DLCO testing consider the impact of the following on test performance: the patient’s
condition for a variable vital capacity, exercise or position; inspiratory manoeuvres; breath-hold and
expiratory manoeuvres; and washout and sample collection manoeuvres. Practical tips are presented in
table 2. On the day of the test, patients should be instructed to refrain from smoking for the entire day
(notes should be taken about the time of patient’s last cigarette) and stay off supplemental oxygen at least
10 min before the test. Regarding residual volume [18], the maximum time of an unforced exhalation is
⩽12 s to reach an optimal level residual volume for patients with severe obstruction. The inspiratory vital
capacity now has a target of >90% of the largest vital capacity in the same lung function session or an
inspiratory vital capacity >85% of the largest vital capacity is acceptable if the alveolar volume (VA) is
within 200 mL or 5% of the highest VA from an acceptable DLCO trial. The time to inspiratory vital
capacity must be <4 s and a longer inspiratory manoeuvre must be noted in the report. The exhalation
post-breath-holding time (BHT) can be up to 12 s on the RGA and <4 s on a classic system. The
repeatability requirement for DLCO states that there must be at least two acceptable manoeuvres that are
within 2 mL·min−1·mmHg−1 (0.67 mmol·min−1·kPa−1) of each other. The between-test waiting time needs
to be a minimum of 4 min and can be up to 10 min for a patient with severe airflow obstruction, with the
patient remaining seated during the wait time. It is recommended to check end-exhalation carbon
monoxide levels prior to inhalation of test gas. This can be used to adjust the test for carbon monoxide
back-pressure and calculate carboxyhaemoglobin (COHb). This allows compensation for water vapour and
carbon dioxide effects.
Reporting and interpretation of case studies
B. Thompson (Australia) and I. Steenbruggen (the Netherlands)
At this workstation, case reports of DLCO testing using the new quality control grading for DLCO
manoeuvres were discussed. It is indicated to always use DLCO corrected for haemoglobin [19] and COHb
where applicable, and to use uncorrected for haemoglobin when no recent haemoglobin is available and to
state this clearly in the report. The goal of interpretation of real case studies was to determine if DLCO was
above or below lower limit of normal and if it was an acceptable test to interpret using the new quality
control grading system for acceptable DLCO results.
Oral presentation session on “A fresh view on assessment of functional status in
COPD”
Accurate and systematic assessment of functional status is a requirement in the management of patients
with COPD [20, 21] and presents a challenge in clinical practice. This oral presentation session provided
new insights into currently used measures of functionality and exercise tolerance in individuals with stable
and unstable COPD.
Take-home messages
• Calibrate volume, pressure and altitude accurately.
• Check if the system settings for dead space and drift are correct on the equipment.
• Maintain and document all quality control measures with the use of a syringe or DLCO simulator.
• BHT needs to be between 8 and 12 s and inspiratory volume needs to be >90%, while keeping the patient
seated between manoeuvres.
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People with COPD report higher levels of cognitive impairment [22] and pain [23] than matched healthy
subjects. Such comorbidities have been linked with lower motor performance and falls in elderly [24, 25];
however, these associations have been poorly explored in individuals with COPD. REID et al. [26] showed
that dual tasking (i.e. backwards spelling while walking at usual or fast paces) causes a larger increase in
oxygenated haemoglobin at the prefrontal cortex and a larger decrease in walking velocity in individuals
with COPD compared with matched healthy subjects. Such increases in prefrontal cortex neural activity
may impact on the safety of ambulation in this population. LOUGHRAN et al. [27] explored the association
of pain and incidence of falls in 883 individuals with COPD. Like studies in older adults [28], people with
COPD and pain showed a greater predicted probability of falling and required more treatment for falls
than controls. Additionally, the predicted probability of falling was progressively greater in more severe
pain stages, with over a third of people suffering from both COPD and severe pain being predicted to fall
over a 2-year time course.
Functional and submaximal constant work rate tests (CWRTs) have been extensively used to assess
cardiorespiratory and muscular endurance in people with COPD [29, 30] but clear implications for
practice are less studied. CASABURI et al. [31] reviewed the exercise duration of CWRTs (75–80% of peak
work rate at incremental exercise test) in 23 published studies involving 5853 participants with COPD.
The authors found that 20% of the tests lasted <3 min and shorter durations were more prevalent in
participants with low peak work rate, independently of height, weight and age. Adjustment to reduce the
baseline work rate in these individuals may increase the likelihood of achieving the recommended exercise
durations between 3 and 8 min [32]. R. Casaburi finished his presentation with two key questions for
future studies: what is the ideal work rate to achieve the target exercise lengthening, and how should the
cut-off be established? Regarding muscular endurance, BERGQVIST et al. [33] explored the extent to which
dynamic and static muscle endurance are similarly affected in COPD. In 30 people with COPD and
30 healthy matched subjects, they found that dynamic quadriceps endurance was significantly decreased in
people with COPD but no differences were found regarding static muscle endurance. As A. Nyberg elicited
during this presentation, these results should motivate health professionals to shift their focus of
intervention from static to dynamic muscle endurance by introducing exercise modalities particularly
designed to this end in daily practice.
The increasing demand to make exercise and pulmonary rehabilitation interventions accessible for
different populations and settings [34] enforces a need for more simple, quick and universally applicable
tests. OLIVEIRA et al. [35] explored the physiological responses of the 1-min sit-to-stand (STS) test and the
6-min walk test (6MWT), aiming to establish whether these tests could be used interchangeably in
patients with COPD and interstitial lung diseases [36]. Strong correlations were found between Borg
dyspnoea scores at the end of both tests. In addition, the number of repetitions in the 1-min STS test was
able to predict 50–63% of the variability in the 6MWT. No correlations were found between tests
regarding physiologic parameters (i.e. blood pressure, heart rate and peripheral oxygen saturation).
Although the 6MWT and 1-min STS test cannot be used interchangeably, the 1-min STS may still provide
important information about patients’ functional status in space-limited settings.
Two studies explored the application of functional tests during acute exacerbations of COPD. MACHADO
et al. [37] showed that a cut-off of 13.7 repetitions in the five-repetition STS test could differentiate
between patients who were admitted to the hospital (n=15) and those who were sent to be treated in the
community (n=32) with a sensitivity of 75% and specificity of 53%. A. Machado further highlighted the
relevance of these results for admission purposes by showing that no other parameter (i.e. age, sex, lung
function, body mass or quadriceps muscle strength) was able to differentiate between these populations.
The discussion among the delegates in the session concluded that future studies could explore the
usefulness of the five-repetition STS test when combined with the measures proposed by the Global
Initiative for Chronic Obstructive Lung Disease (GOLD) [18] (e.g. work of breathing, impaired gas
exchange and comorbidities) to decide on patients’ hospital admission or discharge. OSADNIK et al. [38]
evaluated frailty as a prognostic factor for 90-day readmission in patients hospitalised for an acute
exacerbation of COPD. Frailty was associated with a 4.5-fold risk of readmission; and those readmitted
took longer to perform the five-repetition STS test at the first admission, and improved less in the
five-repetition STS test, 6MWT and quadriceps muscle strength from first admission to 1 month
post-discharge. These results call attention to the need to target frail people with acute exacerbations of
COPD for comprehensive interventions like pulmonary rehabilitation to improve their functional status
and possibly prevent readmissions.
Although functional status is often related to the performance in physical tasks, it may also be assessed
using patient-reported outcome measures, and indeed their use has been advocated to provide a more
patient-centred service [39]. JANSSENS et al. [40] developed and evaluated the psychometric properties of a
comprehensive dyspnoea tool composed of four numeric rating scales in 379 participants with COPD. The
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scale showed adequate internal consistency, test–retest reliability and content validity against the COPD
Assessment Test and the St George’s Respiratory Questionnaire, and responsiveness to pulmonary
rehabilitation. A minimal clinically important difference (MCID) of 4 points was also established.
Finally, all studies emphasised the relevant information that can be retrieved from simple and easily
implemented functional and exercise tests, and that may influence health professionals’ course of practice.
Oral presentation on “Insights into rehabilitation and physical activity of patients
with respiratory diseases”
Improving pulmonary rehabilitation and physical activity uptake and outcomes are currently hot topics in
research and priorities in clinical practice. This oral presentation session included a sample of the highest
quality research currently being conducted in rehabilitation (three studies) and physical activity (four
studies) in people with stable and unstable COPD and in individuals with lung cancer.
Outcomes of inspiratory muscle training may be affected by the device used and the assessment
techniques [41]. VAN HOLLEBEKE et al. [42] showed that training with both mechanical threshold loading
and tapered flow resistive loading devices increases maximal inspiratory pressure (PImax) at different lung
volumes (i.e. residual volume, functional residual capacity and functional residual capacity–total lung
capacity) in healthy individuals. However, only the tapered flow resistive loading increased the inspiratory
peak flow on functional residual capacity and functional residual capacity–total lung capacity against a
resistance of 0%, 20%, 30% and 50% of the baseline PImax, thus improving the velocity of shortening and
muscle power.
Resistance training is a core component of pulmonary rehabilitation [18] but the optimal intensity for
training is yet to be established [43]. BARUSSO-GRÜNINGER et al. [44] compared low load/high repetition
(LL/HR) (30% of the patient’s one-repetition maximum (1RM) for three sets of 15 repetitions) versus high
load/low repetition (HL/LR) (60% 1RM for three sets of eight repetitions) resistance training in a
randomised controlled trial enrolling 27 people with COPD. Improvements in dyspnoea during activities
of daily living, the London Chest Activity of Daily Living scale (physical and total score), 6MWT and
shoulder flexor strength were observed in both groups. However, the symptom subscore of the St George’s
Respiratory Questionnaire improved significantly more in the LL/HR than in the HL/LR group.
In recent years, increasing exercise capacity and physical activity have gained importance as treatment
goals in people with lung cancer [45]. One systematic review and a randomised controlled trial that were
presented aimed to improve knowledge on this field. The findings of the updated Cochrane review on the
effects of exercise training following lung resection for non-small cell lung cancer were explained by
CAVALHERI et al. [46]. Moderate to high certainty evidence suggests that exercise capacity and peripheral
muscle strength improve with exercise training compared to control conditions, with the difference in the
6MWT (mean difference 57 m, 95% CI 34–80 m) being greater than the MCID in this population (from
22 to 42 m) [46]. An improvement in the physical component of general health-related quality of life
(HRQoL) and less dyspnoea were also observed in the exercise training group; however, both outcomes
present low to very low certainty evidence. These findings emphasise the need to refer patients following
lung resection to exercise training programmes. EDBROOKE et al. [47] explored the effects of 8 weeks of
home-based rehabilitation compared with usual care in 92 participants with inoperable lung cancer. At
baseline, they found that ∼70% of participants did not meet the international physical activity guidelines
[48], with low physical activity being significantly associated with the presence of cachexia. No significant
differences were observed between the home-based rehabilitation and control groups at 9 weeks and
6 months with regard to changes in the number of steps per day and step bouts per day (⩾10 min);
however, recruitment is still ongoing.
People with COPD experience a physical activity decline over time of ∼450 steps per year, which impacts
negatively on HRQoL and lung function [49]. KORENY et al. [50] identified three physical activity trajectory
patterns (inactive, active decliners and active improvers) using a cohort of 293 patients with COPD. People
with low exercise capacity and worse dyspnoea presented high probability of being inactive at baseline and
experiencing a natural decline in physical activity (508 steps per year) over the 12-month follow-up period
(inactive trajectory, n=173). However, no determinants at baseline were identified for active decliners
Take-home messages
• Functional status in COPD can be highly affected by pain, frailty and dual tasking.
• Field tests (i.e. 6MWT, 1-min STS and five-repetition STS), laboratory tests (CWRT and computerised
dynamometry) and patient-reported outcome measures can help identify different components of
functional status in patients with COPD.
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(those presenting appropriate levels of physical activity at baseline and a spontaneous decrease in physical
activity after 12 months, n=69) and active improvers (those walking ∼7000 steps per day at baseline and
increasing physical activity after 12 months, n=51). Physical activity interventions should thus be
considered in all patients with COPD because it is currently not possible to predict who will have an active
decline or active improve trajectory over time.
Although exacerbations were not identified as a determinant of physical activity trajectory in the study by
KORENY et al. [50], previous studies have shown that exacerbations have a negative impact on physical
activity [51]. GONZALEZ et al. [52], explored the barriers and enablers associated with physical activity
1 week after hospital discharge for a severe acute exacerbation of COPD. The most frequently reported
barriers were linked to physical and psychological conditions (i.e. incomplete recovery, dyspnoea, lower
mood for this activity and fear of worsening), disliking the activity and suboptimal environmental
conditions. However, only environmental factors were significantly related to fewer steps per day after
discharge (p=0.01). Conversely, daily routine (p=0.05) and hobbies (p=0.008) were the enablers
significantly related with high number of steps per day. These findings should be considered when
interventions are designed to promote physical activity after exacerbations in people with COPD.
Disease-specific fears are important factors to address when referring people to pulmonary rehabilitation
[19, 53] or physical activity interventions. In 34 people with COPD, REIJNDERS et al. [54] observed that
greater dyspnoea-related fear is moderately correlated with low physical activity (steps per day) and people
who reduced their fear of dyspnoea after a pulmonary rehabilitation programme achieved greater
improvements in physical activity. The authors also found that the level of attention to respiratory
sensations (assessed by cerebral activity during a short inspiratory occluded manoeuvre) had a positive
correlation with dyspnoea-related fear (r=0.47) and a negative correlation with the level of physical activity
(r=−0.40). However, this outcome measure only seemed to change after pulmonary rehabilitation in a
subgroup of patients with COPD; thus, further research is needed to confirm this finding, and to identify
whether these patients are more likely to respond to exercise training and physical activity interventions.
Symposium on “The added value of allied healthcare professionals in integrated
respiratory care”
People with chronic respiratory conditions present not only deterioration of lung function and functional
capacity, but also changes in psychosocial abilities and lifestyle, which negatively impact the prognosis of
the disease [20, 55]. Bill Mansell, an individual with sarcoidosis, opened this symposium by emphasising
the importance of having access to a coordinated multidisciplinary and integrated care programme to
achieve the greatest possible benefits in those with chronic respiratory diseases. According to B. Mansell’s
experience, contact with AHPs marked a turning point in his life, and was essential to improving his
self-management and symptom control. B. Mansell’s testimonial on the disease challenges and the
supportive role of AHPs set the scene for an eye-opening symposium about the value of AHPs.
Integrated care programmes have already been demonstrated to reduce the number of readmissions,
improve HRQoL and reduce health care utilisation [56–58]. As Eileen Collins showed in her talk entitled
“Nurses: the spider in the web of integrated respiratory care?”, most of these programmes are led by
specialised nurses because their generalist background gives them a global view of the patient. Moreover,
nurses are seen by patients as easily approachable and trustworthy, which are key aspects to ensure the
success of these programmes. Consequently, nurses are a key element in optimising patient management
in integrated care programmes.
The talk entitled “Occupation therapy: making daily life easier” by Louise Sewell made us aware of the
importance of occupational therapists to increase patients’ performance beyond their functional capacity,
as only this training will allow them to achieve maximum performance during daily life activities [36].
Occupational therapists are responsible for advising patients on how to optimise their daily activities by
Take-home messages
• Outcomes of inspiratory and peripheral muscle training are affected by the equipment used (i.e.
mechanical threshold loading versus tapered flow resistive loading) and type of training implemented
(HL/LR versus LL/HR).
• Exercise training improves exercise capacity and peripheral muscle strength in people following lung
resection for non-small cell lung cancer.
• Physical activity interventions should be considered in all patients with COPD because it is currently not
possible to predict the physical activity trajectory (inactive, active decliners or active improvers) over time.
• Daily routine and hobbies are enablers of physical activity in people with COPD after a hospital admission;
however, geographical factors may act as a barriers to increase physical activity.
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facilitating energy conservation and planning environmental adaptions. Consequently, these healthcare
professionals play a great part in improving some of the skills that matter the most to patients.
Corrine Handson shared the recent guidelines on nutritional care for individuals with COPD promoted by
the Academy of Nutrition and Dietetics in the USA in her talk entitled “Dietary counselling: the fatter the
better?”. Body composition is associated with mortality, with overweight classification presenting the
lowest risk of mortality in patients with COPD. In addition, higher body mass index is associated with
greater lung function (percent predicted forced expiratory volume in 1 s) and with slow lung function
decline in people with COPD. Nevertheless, these findings should be carefully interpreted as the studies
included did not consider the influence of possible confounders. To ensure a successful nutritional
intervention, expert dieticians recommend awakening patients’ motivation to improve their nutritional
condition and actively involving patients in the development of treatment plans. Additional information
about the guidelines can be found at www.andeal.org.
Andreas Von Leupoldt clarified that psychological comorbidities have a negative impact on the prognosis
of COPD [55] in his talk entitled “Psychological counselling: train the brain”. However, they are often
underdiagnosed [59] and poorly treated [60]. Recently, it was observed that greater disease-specific fears
(i.e. fear of dyspnoea, physical activity and disease progression) are related to lower exercise capacity, poor
HRQoL and worse dyspnoea in people with COPD [53]. The evidence to recommend
psychopharmacological treatment is insufficient in COPD and as these medications are related to
side-effects and increased risk of mortality [61], other options should be considered. Cognitive behaviour
therapy is a potential option to improve anxiety and depression in COPD, although its role in other
outcomes (i.e. HRQoL and exacerbations) is still unclear [61, 62]. Pulmonary rehabilitation is also
promising, as it not only improves general and specific psychological comorbidities but may also change
how the brain processes respiratory sensations [54]; however, further research is needed to confirm this
finding. Von Leupoldt concluded his talk by encouraging the audience to train not only people’s lungs but
also their brain.
Thematic poster session on “Nursing care across the spectrum of respiratory
illness”
This thematic poster session provided an overview of state-of-the-art advances in nursing care related to
respiratory conditions by focusing on three main themes: nurse-led interventions; training and
development for respiratory nurses; and electronic learning (e-learning).
Nurse-led interventions
PEREIRA et al. [63] conducted a systematic review to identify the impact of nurse-led interventions related
to self-care in COPD. After full-text reviews, only one randomised clinical trial could be included in this
review [64]. The included study aimed to identify the effect of a home-based pulmonary rehabilitation
programme on self-care behaviours of COPD patients in GOLD stage 2 and 3. Patients were randomised
to pulmonary rehabilitation or routine care consisting of drug therapy (20 in each group) from a
specialised centre in Iran. As self-care is difficult to assess due to the lack of reliable instruments [65],
authors evaluated physical consequences of the lack of self-care. Thus, the intervention had a positive
effect on fatigue, activities of daily living and quality of life. PEREIRA et al. [63] concluded that there is a
need to develop robust studies assessing the impact of nurse-led interventions on the capacity for self-care
of people with COPD.
PEDERSEN et al. [66] presented the results of a pilot study to detect early signs that predict the onset of an
acute exacerbation of COPD in patients with home long-term noninvasive therapy (LT-NIV). This study
used a combination of automatic recordings from LT-NIV devices as well as patients’ symptoms
(submitted via online app or phone calls). Their results showed that an increased use of acute inhaler
Take-home messages
• Contacts with AHPs mark a turning point in patients’ life, and are essential to improve self-management
and symptoms control.
• Occupational therapists optimise the daily life of patients by facilitating energy conversation strategies
and planning environmental adaptions.
• Nurses are key elements in optimising patient management in integrated care programmes.
• Nutritional interventions are essential in the management of COPD because body composition is
associated with mortality.
• Pulmonary rehabilitation improves general and specific psychological comorbidities, which impact
negatively on the prognosis of COPD, and may also change how the brain processes respiratory
sensations
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medication was the best predictor of COPD exacerbations, followed by increased mucus and higher
respiratory rate.
Training and development for respiratory nurses
The importance of continuous education in respiratory nursing care was also highlighted in this poster
session. SAVOCIC et al. [67] described the level of knowledge on chest drainage before and after training for
417 participants in Croatia. The initial average level was 65% (9–99%) improving to 84% (22–99%)
post-training. MONGODI et al. [68] presented a short theoretical training (3 h during the diploma in critical
nursing) to improve the interpretation of lung sliding ultrasound images to detect the presence of a
pneumothorax. After the training, a significant improvement (p<0.001) was found. However, the average
correct interpretations remained rather low (37.1±15.3%), which suggests a potential change is needed in
clinical practice and education reinforcement for this clinical assessment. Moreover, a qualitative research
project captured an important identity breach between the current practice and the visualised future for
respiratory nurses in Spain [69]. Senior respiratory nurses (n=12) described current practice in three
themes: technical skills, multidisciplinary alliances and self-learning. These themes were linked with
continuous education, motivation and personal efforts to update knowledge and skills. In addition,
participants detected challenges for their professional development. They aimed to develop a regulated
framework to recognise a respiratory nursing speciality, specialised clinical academic training and the use
of a standardised taxonomy for respiratory nursing care. Interestingly, these senior respiratory nurses
recognised engagement and collaboration within scientific societies as important to achieve their desired
specialist role in respiratory nursing. Professional networks were also presented as a potential opportunity
to develop the profile of respiratory professionals. For example, the UK network SiLVaH (Specialist in
Long-term Ventilation at Home) aims to support nurses and AHPs working in the community setting [70].
E-learning
Two innovative projects highlighted e-learning as an education opportunity to enhance skills and update
knowledge between respiratory professionals. Ecare-COPD [71] is an online training programme
integrating modules on self-management, pulmonary rehabilitation and virtual simulations for clinical
scenarios in COPD. This e-learning tool was available in three levels (nursing students, general nurses and
specialist nurses) with positive feedback from users in terms of usefulness, easiness and intention to use.
Similarly, a group from New Zealand [72] developed an online training programme for respiratory
professionals including four modules: asthma fundamentals; asthma management; COPD management;
and health-promoting practice. Participants completing these modules found this e-learning tool
enjoyable, easy to complete and relevant to their practice. Additionally, qualitative data revealed six major
themes to inform future development of the modules: increased confidence; increased knowledge;
improved and informed practice; educate patients; educate colleagues; and culturally appropriate care.
Concluding remarks
This article highlights some of the most memorable 2019 ERS International Congress sessions, and provides
readers with valuable insight into some of the emerging and future areas affecting clinical practice of AHPs.
The authors want to inspire the readers’ enthusiasm to appreciate the value of keeping abreast of an
ever-changing clinical landscape within their field of interest. With this in mind, the authors welcome everyone
to join them in Vienna in 2020 for the next highly successful ERS International Congress. Auf Wiedersehen!
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